Theranostics in Oncology—Thriving, Now More than Ever

Theranostics in Oncology—Thriving, Now More than Ever

Tracing its roots back to the 1940s, theranostics in nuclear oncology has proved successful mainly due to the beneficial effects of image-guided therapeutic concepts for patients afflicted with a variety of different cancers. The majority of these treatments are not only characterized by substantial...

Full description

Bibliographic Details
Main Authors: Rudolf A. Werner, Takahiro Higuchi, Martin G. Pomper, Steven P. Rowe
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Diagnostics
Subjects:
theranostics
somatostatin receptor
SSTR
prostate-specific membrane antigen
PSMA
prostate cancer
Online Access:https://www.mdpi.com/2075-4418/11/5/805

Similar Items

Similar Items